These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24249720)

  • 1. Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.
    D'Amario D; Leone AM; Iaconelli A; Luciani N; Gaudino M; Kannappan R; Manchi M; Severino A; Shin SH; Graziani F; Biasillo G; Macchione A; Smaldone C; De Maria GL; Cellini C; Siracusano A; Ottaviani L; Massetti M; Goichberg P; Leri A; Anversa P; Crea F
    Circulation; 2014 Jan; 129(2):157-72. PubMed ID: 24249720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
    D'Amario D; Leone AM; Iaconelli A; Luciani N; Gaudino M; Kannappan R; Manchi M; Severino A; Shin SH; Graziani F; Biasillo G; Macchione A; Smaldone C; Cellini C; Siracusano A; Ottaviani L; Massetti M; Goichberg P; Leri A; Anversa P; Crea F
    Circulation; 2014 Sep; 130(13):e118-9. PubMed ID: 25245852
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Li and Shen regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
    Li Y; Shen Z
    Circulation; 2014 Sep; 130(13):e117. PubMed ID: 25245851
    [No Abstract]   [Full Text] [Related]  

  • 5. Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium.
    Latham N; Ye B; Jackson R; Lam BK; Kuraitis D; Ruel M; Suuronen EJ; Stewart DJ; Davis DR
    Circulation; 2013 Sep; 128(11 Suppl 1):S105-12. PubMed ID: 24030393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration.
    D'Amario D; Cabral-Da-Silva MC; Zheng H; Fiorini C; Goichberg P; Steadman E; Ferreira-Martins J; Sanada F; Piccoli M; Cappetta D; D'Alessandro DA; Michler RE; Hosoda T; Anastasia L; Rota M; Leri A; Anversa P; Kajstura J
    Circ Res; 2011 Jun; 108(12):1467-81. PubMed ID: 21546606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the future with stem cells.
    Mohsin S; Wu JC; Sussman MA
    Circulation; 2014 Jan; 129(2):136-8. PubMed ID: 24249719
    [No Abstract]   [Full Text] [Related]  

  • 9. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-term results of coronary bypass graft surgery in patients with ischaemic left ventricular systolic dysfunction and no detected myocardial viability.
    Liu J; Liu Z; Chen A; Wang Z; Zhou M; Cai J; Zhao Q
    Interact Cardiovasc Thorac Surg; 2016 Jun; 22(6):738-43. PubMed ID: 26912575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival.
    Urbanek K; Rota M; Cascapera S; Bearzi C; Nascimbene A; De Angelis A; Hosoda T; Chimenti S; Baker M; Limana F; Nurzynska D; Torella D; Rotatori F; Rastaldo R; Musso E; Quaini F; Leri A; Kajstura J; Anversa P
    Circ Res; 2005 Sep; 97(7):663-73. PubMed ID: 16141414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.
    Depré C; Vanoverschelde JL; Gerber B; Borgers M; Melin JA; Dion R
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):371-8. PubMed ID: 9040632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion.
    Huang C; Gu H; Yu Q; Manukyan MC; Poynter JA; Wang M
    PLoS One; 2011; 6(12):e29246. PubMed ID: 22195033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
    Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
    Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endomyocardial biopsy foretells ventricular function recovery after coronary artery bypass grafting.
    Moreno PL; Wender OB; Barra M; Pellanda LC; Rohde LE; Clausell N
    Arq Bras Cardiol; 2004 Nov; 83(5):379-84; 373-8. PubMed ID: 15543357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy.
    Bolli R; Tang XL; Sanganalmath SK; Rimoldi O; Mosna F; Abdel-Latif A; Jneid H; Rota M; Leri A; Kajstura J
    Circulation; 2013 Jul; 128(2):122-31. PubMed ID: 23757309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium.
    Ribeiro GA; da Costa CE; Lopes MM; Albuquerque AN; Antoniali F; Reinert GA; Franchini KG
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):196-201. PubMed ID: 16388958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
    Bolli R; Chugh AR; D'Amario D; Loughran JH; Stoddard MF; Ikram S; Beache GM; Wagner SG; Leri A; Hosoda T; Sanada F; Elmore JB; Goichberg P; Cappetta D; Solankhi NK; Fahsah I; Rokosh DG; Slaughter MS; Kajstura J; Anversa P
    Lancet; 2011 Nov; 378(9806):1847-57. PubMed ID: 22088800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic response, circulating endothelial progenitor cells and cardiopulmonary bypass.
    Denizot Y; Nathan N
    Cytotherapy; 2010 Oct; 12(6):846. PubMed ID: 20334611
    [No Abstract]   [Full Text] [Related]  

  • 20. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
    Donndorf P; Kundt G; Kaminski A; Yerebakan C; Liebold A; Steinhoff G; Glass A
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):911-20. PubMed ID: 21376346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.